Request Deal Involvement
Frazier Life Sciences and Lightspeed Venture Partners led a $150m Series C round in Scorpion Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Precision AQ
legal advisors
Cooley
or
Principals
target
SCORPION THERAPEUTICS INC
bidder
FRAZIER LIFE SCIENCES
bidder
LIGHTSPEED VENTURE PARTNERS
bidder
WILLETT ADVISORS
bidder
OMEGA FUNDS
bidder
VIDA VENTURES
bidder
ATLAS VENTURE LP
bidder
ABINGWORTH MANAGEMENT
bidder
FIDELITY MANAGEMENT & RESEARCH COMPANY
bidder
BOXER CAPITAL
bidder
ECOR1 CAPITAL
bidder
SURVEYOR CAPITAL
bidder
THE INVUS GROUP LLC
bidder
WELLINGTON MANAGEMENT
bidder
ORBIMED ADVISORS LLC
bidder
LOGOS CAPITAL
bidder
NEXTECH INVEST
bidder
WOODLINE PARTNERS
bidder
CASDIN CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite